How Weight Loss Injections Like Mounjaro and Ozempic Affect Sensory Perception

New research reveals that popular weight loss injections may significantly impact taste and smell, with nearly 50% increased risk of sensory changes.

Popular weight loss medications like Mounjaro and Ozempic have been associated with a nearly 50% increased risk of damaged taste and smell, according to recent studies. While these GLP-1 drugs are well-known for their appetite-suppressing effects, helping users lose around 15% of their body weight, their impact on sensory perception is less understood.

These medications are widely prescribed for managing type 2 diabetes and obesity. Mounjaro for instance, is available privately for patients with a BMI of 27 and a weight-related condition, while Ozempic is recommended when other medications fail to manage diabetes effectively.

Currently, an estimated 1.6 million people in the UK are using these injections, with many awaiting the approval of a new pill form of Wegovy.

Study Findings on Sensory Changes

A comprehensive study published in JAMA Otolaryngology analyzed data from over 870,000 patients across 170 healthcare institutions worldwide between 2017 and 2026.

The research focused on individuals with type 2 diabetes, half of whom were prescribed GLP-1s, while the other half managed their condition with different diabetes medications.

The results indicated that patients using GLP-1 drugs were about 50% more likely to report changes in taste and smell compared to those on other medications. However, the researchers emphasized that this side effect remains relatively rare. People with type 2 diabetes are already prone to sensory issues due to nerve damage and poor blood flow, and these medications may exacerbate these effects.

The Science Behind Sensory Alterations

GLP-1 drugs influence not only the gut and brain areas that control appetite but also taste bud cells and brain regions responsible for processing taste, smell, and reward. Dr. Madusha Peiris an expert in appetite regulation, explains that taste perception involves more than just the tongue. ‘When we eat, we consciously register sweet, bitter, umami, and sour, but the same nutrients are being ‘tasted’ a second time in the gut,’ she says.

The gut is lined with sensor cells that release hormones like GLP-1, signaling fullness to the brain. This shared wiring between taste and fullness is why these drugs can affect sensory perception. With elevated GLP-1 levels, the body’s nutrient-sensing system is pushed beyond its normal limits, potentially altering taste and smell.

Patient Experiences and Expert Insights

A 2026 study found that around one in five patients taking OzempicWegovy or Mounjaro reported foods tasting saltier or sweeter than before. Interestingly, the perception of bitterness or sourness remained unchanged. Users who noticed these taste changes were also twice as likely to feel fuller, particularly those who found food sweeter. Among these users, 67% reported a reduction in appetite and were 85% more likely to experience a decrease in cravings.

Despite these findings, experts caution that changes in taste alone are not sufficient to drive significant weight loss. Factors such as physical exercise, diet, sleep, stress, and long-term eating patterns play crucial roles in weight management. The recent approval of a new pill form of Wegovy in the UK is expected to increase the uptake of these medications, with many preferring tablets over injections.

Expert Opinions on Sensory Changes

Mir Ali a bariatric surgeon, noted that taste and smell dysfunction from GLP-1 medications is not widespread. He advised that the benefits of achieving a healthy weight far outweigh any temporary sensory changes. ‘As weight stabilizes, taste and smell tend to return to a more normal state,’ he said.

Zhaoping Li a professor of clinical medicine, echoed this sentiment, stating that taste and smell impairment caused by medication can be resolved by discontinuing the drug. She emphasized that these side effects have not significantly impacted patient acceptance of GLP-1 medications.

The sense of smell is closely linked to the brain’s regions involved in behavioral and emotional responses, influencing food choices, social interactions, and safety alerts. Impaired smell can be temporary or permanent, often caused by allergies, infections, or age-related changes. Similarly, taste impairment can result from respiratory illnesses, allergies, or certain medications.

As research continues, the connection between GLP-1 drugs and sensory changes remains a topic of interest. While these medications offer significant benefits for weight management and diabetes control, understanding their full range of effects is essential for both patients and healthcare providers.